pinacidil
Trade name: Pindac
Small moleculeapproved
Approved
Dec 28, 1989
Pinacidil is a clinically effective vasodilator used for the treatment of hypertension. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1980s
- Dec 28, 1989
Earliest FDA Approval
- Dec 28, 1989
Leo Pharma — NDA Secondary Org
Indications
Approved for
Mechanism of action
Sulfonylurea receptor 2, Kir6.2 opener
SUR2 is binding site
Approval history
- approvedDec 28, 1989
Chemistry & pharmacology
Loading structure…
SMILES
CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C- Mol. weight
- 245.33 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1159 ↗
- WikipediaPinacidil ↗
- NCATSBB4UGO5K0D ↗
- ChEMBLCHEMBL1200338 ↗
Also known as
- pinacidil
- pinacidil
- pinacidil
- pinacidil
- pinacidil
- pinacidil
- pinacidil
- pinacidil
- (+/-)-pinacidil
- pinacidil hydrate
- pinacidil hydrate
- pinacidil hydrate
- pinacidil monohydrate
- pindac
- pindac
- pindac
- pindac
- (r,s)-pinacidil
- (r,s)-pinacidil
- (r,s)-pinacidil
- (r,s)-pinacidil
- (r,s)-pinacidil
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Eli Lilly | For profit | NDA | — |
| Leo Pharma | For profit | NDA2 | Dec 28, 1989 |